Newly Public Biotechs With Late-Stage Pipelines Make Strong IPO Showings.

Sorry, there's nothing here.

Cite this paper

@article{Brower2004NewlyPB, title={Newly Public Biotechs With Late-Stage Pipelines Make Strong IPO Showings.}, author={Amanda Brower}, journal={Biotechnology healthcare}, year={2004}, volume={1 2}, pages={18-9} }